logo
Sign in

GREENLIGHT BIOSCIENCES INC.

Medford, MA · Founded 2008 · Agritech · Acquired

RNA interference (RNAi) bioagent using double-stranded RNA to activate plant defense mechanisms against soil-borne fungal pathogens in crops

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · greenlightbiosciences.com

Sector
Agritech
Headquarters
Medford, MA
Founded
2008
Latest Form D
$103M, Jun 2020
Total capital
$178M
Federal grants
$174K
1 award · 2024
Rank in peer group#34 of 36
Private capital raised
$178M
5 Form D · last Jun 2020
76 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
15
25 pending · first 2019
Rank in peer group#2 of 36

Capital timeline

201320152017201920212023FEDERAL ↑EQUITY ↓Cumulative $178M$174K1st Form D$7M2nd Form D$20M5th Form D$103M
201320152017201920212023FEDERAL ↑EQUITY ↓Cumulative $178M$174K5th Form D$103M

Latest events

  • Federal grantAgriculture · **awards Issued Prior To January 20, 2025, Were Funded Under Previous Administrations And May Not Reflect The Priorities And Policies Of The Current Administration.** Fungal Pathogens Cause Crop Yield And Quality Reduction Leading To Billions Of Dollars Lost Annually In The US. Fungicide Resistance Development And Environmental Toxicity Drive An Urgent Need For Novel Fungal Control Strategies. Sudden Death Syndrome (sds) In Soybeans Is Caused By The Soil Borne Fungus Fusarium Virguliforme Which $174K
  • Private capital raisedForm D · SEC · 5th filing$103M
  • Private capital raisedForm D · SEC · 4th filing$38.7M
  • Private capital raisedForm D · SEC · 3rd filing$10M
  • Private capital raisedForm D · SEC · 2nd filing$20M
  • Private capital raisedForm D · SEC · 1st filing$7M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 36 peers

Line = median

Agritech · Molecule

  • Federal grantsBelow median
  • Granted patents#2 · top 6%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Andrey ZarurExecutive Officer, DirectorNamed in SEC Form D filings
  • Charles CooneyDirectorNamed in SEC Form D filings
  • David FurneauxDirectorNamed in SEC Form D filings
  • Eric O'BrienDirectorNamed in SEC Form D filings
  • Ganesh KishoreDirectorNamed in SEC Form D filings
  • Greg LucierDirectorNamed in SEC Form D filings
Show all 15 people
  • James SwartzDirectorNamed in SEC Form D filings
  • Jason DingesDirectorNamed in SEC Form D filings
  • Jonathan FlemingDirectorNamed in SEC Form D filings
  • Marta Ortega-ValleExecutive OfficerNamed in SEC Form D filings
  • Martha SchlicherDirectorNamed in SEC Form D filings
  • Matthew WalkerDirectorNamed in SEC Form D filings
  • Michael LiangDirectorNamed in SEC Form D filings
  • Neil RenningerDirectorNamed in SEC Form D filings
  • William L. BlakeExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 15 granted of 40
Show all 40 patent records

Related companies, and why

Regulatory activity · Agritech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .